Association between coronavirus disease 2019 vaccination and hypercholesterolemia: A cross-sectional study from the 2023 National Health Interview Survey

Hyperlipidemia, a prevalent metabolic disorder, affects global health. Although extensive safety data exist for COVID-19 vaccines, their metabolic effects remain insufficiently studied. This study investigated the association between COVID-19 vaccination and hyperlipidemia development to inform public health policy. This study was based on the adult data from the National Health Interview Survey database in 2023. After excluding the data that did not meet the criteria, baseline statistics, weighted multivariate logistic regression analysis, and risk stratification analysis were conducted to explore the relationship between COVID-19 vaccination and hypercholesterolemia. Finally, the predictive value of COVID-19 vaccination for hyperlipidemia was evaluated using receiver operating characteristic (ROC) curve analysis. This study included a total of 29,522 participants. After screening, 15,502 participants were enrolled. There were significant differences in covariates such as COVID-19 vaccination, hyperlipidemia, marital status, and other covariates between the hypercholesterolemia group (n = 3689) and the control group (n = 11,813) (P < .001). Subsequently, 3 generalized linear models and subgroup analyses all showed that COVID-19 vaccination was associated with hypercholesterolemia (odds ratios > 1) and was not significantly interfered with by other covariates. Notably, among cohabiting unmarried individuals without hypertension, those vaccinated against COVID-19 had the highest risk of hypercholesterolemia. Finally, the ROC curve indicated that COVID-19 vaccination had a certain predictive effect on the risk of hypercholesterolemia. This cross-sectional study observed an association between COVID-19 vaccination and hypercholesterolemia, providing a valuable reference for subsequent research. However, this study has a cross-sectional design, subsequent studies should adopt a longitudinal approach to further verify the causality of these associations.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2025-11-28
DOI
https://doi.org/10.1097/md.0000000000046221
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association between coronavirus disease 2019 vaccination and hypercholesterolemia: A cross-sectional study from the 2023 National Health Interview Survey

Guofu Zhu, Xu Xu, Zhiyong Huang
Medicine
SARS-CoV-2 and COVID-19 Research
article

Association between coronavirus disease 2019 vaccination and hypercholesterolemia: A cross-sectional study from the 2023 National Health Interview Survey

Guofu Zhu, Xu Xu, Zhiyong Huang
article en

Abstract

Hyperlipidemia, a prevalent metabolic disorder, affects global health. Although extensive safety data exist for COVID-19 vaccines, their metabolic effects remain insufficiently studied. This study investigated the association between COVID-19 vaccination and hyperlipidemia development to inform public health policy. This study was based on the adult data from the National Health Interview Survey database in 2023. After excluding the data that did not meet the criteria, baseline statistics, weighted multivariate logistic regression analysis, and risk stratification analysis were conducted to explore the relationship between COVID-19 vaccination and hypercholesterolemia. Finally, the predictive value of COVID-19 vaccination for hyperlipidemia was evaluated using receiver operating characteristic (ROC) curve analysis. This study included a total of 29,522 participants. After screening, 15,502 participants were enrolled. There were significant differences in covariates such as COVID-19 vaccination, hyperlipidemia, marital status, and other covariates between the hypercholesterolemia group (n = 3689) and the control group (n = 11,813) (P < .001). Subsequently, 3 generalized linear models and subgroup analyses all showed that COVID-19 vaccination was associated with hypercholesterolemia (odds ratios > 1) and was not significantly interfered with by other covariates. Notably, among cohabiting unmarried individuals without hypertension, those vaccinated against COVID-19 had the highest risk of hypercholesterolemia. Finally, the ROC curve indicated that COVID-19 vaccination had a certain predictive effect on the risk of hypercholesterolemia. This cross-sectional study observed an association between COVID-19 vaccination and hypercholesterolemia, providing a valuable reference for subsequent research. However, this study has a cross-sectional design, subsequent studies should adopt a longitudinal approach to further verify the causality of these associations.

MedicineVol. 104(48)
Kunming Medical University (CN), CITIC Group (China) (CN), S.P.E.C.I.E.S. (US)
Openalex Percentile: Top 56%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.